In addition, the secretory mode of CHI3L1 makes it a promising target for cancer treatment as shown by several chemical inhibitors of CHI3L1 17, 18 and neutralizing antibodies 19, 20 developed. The gene discussed is CHI3L1; the disease is cancer.